Levels of complement proteins and functional activity of the alternate complement pathway were assessed in 39 patients with pneumococcal pneumonia. Mean levels of C3 and properdin and the functional activity of the alternate pathway in acute sera were significantly (P < 0.05) below normal, whereas levels of components of the early classical pathway were normal. Although levels of factor B were in the normal range, they correlated significantly with C3 levels; there was no significant relation between C3 levels and C4 or Clq levels. The 19 patients with pneumococcal pneumonia and bacteremia had significantly lower mean values of properdin and factor B than the 20 patients without bacteremia, suggesting a more severe depression of the alternate complement pathway with bacteremia. During convalescence, complement levels were normal or elevated in most of the patients, but mean levels of properdin remained significantly below normal in bacteremic patients. Functional activity of the alternate pathway also remained below normal. These results indicate that there is a selective depression of the alternate pathway in patients with pneumococcal pneumonia, and they are consistent with the concept that the alternate pathway has an important role in host defenses in pneumococcal infection.
Both the classical and alternate (properdin) complement pathways have been shown to participate in opsonization of pneumococci (9, 26) . The alternate pathway may be the more important determinant of natural immunity to pneumococci in humans, but comparative studies of the two pathways in naturally occurring pneumococcal infection have been few. Reed et al. (16) demonstrated recently that levels of factor B, a component of the alternate pathway, were below normal in patients with pneumococcal infections, whereas levels of components of the early classical pathway (Clq and C4) were within normal limits. These findings suggested a selective alteration of the alternate complement pathway in patients with pneumococcal infection. In the present studies, complement components of the classical and alternate pathways and functional activity of the alternate pathway were measured in patients with pneumococcal pneumonia. The results showed a selective depression of the alternate pathway during the acute phase of the infection, with the depression being more marked in patients with pneumonia accompanied by pneumococcal bacteremia.
MATERIALS AND METHODS
Patients. Thirty-nine patients who were admitted to the hospital with fever, purulent sputum, and a clinical history suggestive of acute bacterial pneumonia were studied. All had roentgenographic evidence of pulmonary consolidation. Cultures of blood and sputum were obtained before antibiotic therapy, and Streptococcus pneumoniae was isolated from cultures of the blood of 19 cases, in pure culture from transtracheal aspirates of 14 cases, and as the predominant organism from expectorated sputum of 6 cases. The latter six patients showed clinical improvement within 72 h on low doses of penicillin G. The mean age of the subjects was 56.8 years (range, 25 to 80 years). Thirty-one of the patients were males; there were 32 whites and 7 blacks. Thirteen of the patients were considered by their physicians to be alcoholics, and 11 subjects had clinical and laboratory evidence of chronic obstructive airways disease. None of the patients had documented collagen-vascular disease, neoplastic disease, cirrhosis, or sickle cell disease. Acute sera were obtained within 48 h after admission to the hospital. Convalescent sera were obtained 7 to 21 days after admission (mean, 13.5 days), except from three patients who died and from three individuals who were lost to follow-up. Blood to have a more severe illness. There were significantly more pleural effusions in bacteremic patients, as judged by roentgenograms obtained in the lateral decubitus position, and three patients in the bacteremic group had documented pleural empyema. Fever persisted longer in bacteremic patients, and they had a significantly longer stay in the hospital. The only three deaths in the study occurred in patients with bacteremia. Both groups of patients had similar underlying illnesses, with the exception that significantly more bacteremic patients were considered to be alcoholics by their physicians. However, as indicated in Table 4 , mean complement levels for 10 alcoholic patients with pneumococcal bacteremia did not differ significantly from mean complement levels of 9 bacteremic patients who were not alcoholics.
Pneumococcal serotypes. The possibility of a relationship between the serotype of the infecting pneumococcus and complement levels was considered. Seven of the 39 patients in the study were infected with type 3 pneumococci; four cases were due to type 4, and three cases each were caused by types 6, 19, and 23. There were 14 different pneumococcal types associated with the remaining 19 cases. The number of patients infected with any given serotype was too small to warrant statistical analysis of the results. However, it was apparent that altered complement levels were associated with pneumonia caused by any one of a variety of pneumococcal serotypes.
Capsular polysaccharide antigenemia. Complement levels were evaluated in relation to capsular polysaccharide antigenemia. Capsular polysaccharide was detected by counterimmunoelectrophoresis in acute sera from 11 of the 39 patients. Since each of these 11 patients was also bacteremic, complement levels could not be evaluated independently of bacteremia. The antigenemic patients were therefore compared with the eight bacteremic patients who were not antigenemic. Hemolytic complement and mean levels of Clq, C3, C4, C5, and factor B were not significantly different in the two groups. The In extending these observations, we compared complement levels of the patients with pneumonia who had an accompanying pneumococcal bacteremia with those who were abacteremic. Properdin levels and functional activity of the alternate pathway were below normal in both groups of patients, but properdin levels were significantly lower in the bacteremic patients. In addition, bacteremic patients had lower levels of factor B, C5, and hemolytic complement than the abacteremic subjects. Clq and C4 levels did not differ significantly in the two groups.
There was, therefore, evidence of selective depression of the alternate complement pathway in both bacteremic and abacteremic patients, but the changes in complement were greater in degree in the bacteremic individuals.
The reasons for depression of the alternate pathway in pneumococcal pneumonia and for the observed differences in complement levels of bacteremic and abacteremic patients are not clear. One possible explanation for the findings may be a selective activation and consumption of alternate pathway proteins in pneumococcal pneumonia. In varying degrees, most serotypes of pneumococci are able to activate the alternate pathway in vitro (24) (17) in studies of pneumococcal pneumonia in dogs concluded that there was a loss of bactericidal activity for pneumococci in the blood after the development of pneumococcal bacteremia; cessation of bacteremia was accompanied by an increase in the bactericidal activity of the blood. Unfortunately, in these early studies the specific serum factors responsible for the bactericidal capacity of the serum were not defined, and we can only surmise that complement was a factor. In the present studies, patients with bacteremia had evidence of a more severe infection than did abacteremic patients, as has been noted by a number of investigators in both the pre-and postantibiotic eras (21, 22) . If increased utilization of complement were a major determinant of complement levels in pneumococcal pneumonia, it seems possible that the extent of the infection could have influenced the amount of complement consumed. However, it is not certain that the reduction in complement levels we observed was due to increased consumption of complement. Low complement levels in several disease states have been shown to be due to increased complement consumption, but fractional catabolic rates must be determined to prove hypercatabolism.
Patients who develop pneumococcal pneu- (25) . This failure is due to reduced functional activity of the alternate pathway (10) , which may be caused by a deficiency of C3 proactivator convertase (alternate pathway factor lp) (11). Individuals with sickle cell disease are especially susceptible to severe infections, and particularly to pneumococcal meningitis (18, 20) . If there were preexisting abnormalities of the alternate pathway in the patients we studied, these abnormalities might have predisposed to the development of pneumococcal pneumonia or of pneumococcal bacteremia. This possibility cannot be excluded by the present results. Studies of complement levels in convalescent sera did establish that most of the patients were able to increase complement levels in the nornal range as the infection subsided. Mean levels of factor B, properdin, and C3, and the functional activity of the alternate pathway all increased significantly between the acute and convalescent phases of infection, and factor B and C3 were significantly above the normal range during convalescence. These latter changes could reflect the function of factor B and C3 as so-called acute-phase reactants (19) and do not necessarily indicate that the patients had normal levels of the components at the time the infection was acquired. Mean properdin levels returned to the normal range for the pneumonia patients as a whole during convalescence, but the mean level for bacteremic patients remained significantly below normal during the period in which the patients were observed. In addition, mean functional activity of the altemate pathway was slightly below normal during convalescence. On the basis of these findings we cannot exclude a preexisting abnormality of complement in at least some of the patients. We attempted to exclude from the study patients who had diseases known to be associated with decreased complement levels. There were, however, 13 patients who were considered by their physicians to be alcoholics. Alcoholism, when complicated by hepatic cirrhosis, has been associated with depressed levels of C3, factor B, C4, C5, and hemolytic complement (2, 6, 15) . None of the patients included in the present study had clinical or laboratory evidence of cirrhosis, but an attempt was made to evaluate the possible effects of alcoholism on complement levels. Alcoholic and nonalcoholic subjects with bacteremic pneumococcal bacteremia were compared. No significant differences between COMPLEMENT IN PNEUMONIA these two groups were found, suggesting that alcoholism per se was not a major determinant of the low complement levels seen in bacteremic individuals.
Activation of complement by pneumococci seems to be initiated principally by antigens in the cell wall, but certain type-specific capsular polysaccharides can also activate the alternate pathway. Capsular polysaccharide is occasionally present in the circulation in pneumococcal pneumonia, but the concentration of circulating antigen is usually much lower than the quantity of antigen required for activation of complement in vitro (24) . In the present study, complement levels in patients with antigenemia did not differ significantly from the complement levels of non-antigenemic patients. Properdin levels and functional activity of the alternate pathway were lower in antigenemic than in non-antigenemic individuals, but these differences were not statistically significant (P < 0.10).
